Literature DB >> 28778103

Central Venous Catheter-Associated Deep Venous Thrombosis in Critically Ill Children.

Edward Vincent S Faustino1.   

Abstract

The presence of a central venous catheter and admission to the intensive care unit are the most important risk factors for deep venous thrombosis (DVT) in children. At least 18% of critically ill children with a catheter develop radiologically confirmed catheter-associated thrombosis. Clinically apparent thrombosis occurs in 3% of critically ill children with a catheter and is associated with 8 additional days of mechanical ventilation. Even when the thrombus is initially asymptomatic, 8 to 18% of critically ill children with catheter-associated thrombosis develop postthrombotic syndrome. Thrombosis is uncommon within 24 hours after insertion of a nontunneled catheter in critically ill children, but nearly all thrombi have developed by 4 days after insertion. Hypercoagulability during or immediately after insertion of the catheter plays an essential role in the development of thrombosis. Pharmacologic prophylaxis, including local anticoagulation with heparin-bonded catheter, has not been shown to reduce the risk of catheter-related thrombosis in children. Systemic anticoagulation in critically ill children started soon after the insertion of the catheter, however, may be beneficial. A multicenter clinical trial that is testing this hypothesis is currently underway. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2017        PMID: 28778103     DOI: 10.1055/s-0037-1603938

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  2 in total

1.  Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.

Authors:  Marie-Claude Pelland-Marcotte; Nour Amiri; Maria L Avila; Leonardo R Brandão
Journal:  Cochrane Database Syst Rev       Date:  2020-06-18

2.  Thrombosis and hemorrhage experienced by hospitalized children with SARS-CoV-2 infection or MIS-C: Results of the PICNIC registry.

Authors:  Sarah Tehseen; Suzan Williams; Joan Robinson; Shaun K Morris; Ari Bitnun; Peter Gill; Tala El Tal; Ann Yeh; Carmen Yea; Rolando Ulloa-Gutierrez; Helena Brenes-Chacon; Adriana Yock-Corrales; Gabriela Ivankovich-Escoto; Alejandra Soriano-Fallas; Jesse Papenburg; Marie-Astrid Lefebvre; Rosie Scuccimarri; Alireza Nateghian; Behzad Haghighi Aski; Rachel Dwilow; Jared Bullard; Suzette Cooke; Lea Restivo; Alison Lopez; Manish Sadarangani; Ashley Roberts; Michelle Forbes; Nicole Le Saux; Jennifer Bowes; Rupeena Purewal; Janell Lautermilch; Ann Bayliss; Jacqueline K Wong; Kirk Leifso; Cheryl Foo; Luc Panetta; Fatima Kakkar; Dominique Piche; Isabelle Viel-Theriault; Joanna Merckx; Lani Lieberman
Journal:  Pediatr Blood Cancer       Date:  2022-06-11       Impact factor: 3.838

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.